The recent disruptions in global chains have highlighted the necessity of securing essential medications like Ivermectin. Relying on overseas manufacturers exposes nations to considerable vulnerabilities, including shipping delays, expense fluctuations, and even trade risks. Transitioning towards domestic sourcing of Ivermectin offers a multitude o